3 0 0 3 3 -5 -I n table 4, the entries stating "Add-on to maximally tolerated statin dose if failing to reach <1·8 mg/dL" should have stated "Add-on to maximally tolerated statin dose if failing to reach <1·8 mmol/L." In Figure 1 , the p values for EMPA-REG OUTCOME and SUSTAIN 6 regarding primary composite MACE outcome have been corrected from <0·001 (testing for non-inferiority) for both entries to 0·04 for EMPA-REG OUTCOME and 0·02 for SUSTAIN 6 (testing for inferiority). This correction has been made to the online version as of April 3, 2017.
Correction to Lancet Diabetes Endocrinol 2017: 5: 174-83
Olbers T, Beamish AJ, Gronowitz E, et al. Laparoscopic Roux-en-Y gastric concentrations do not decrease as markedly as in purely aerobic activities, in part because the duration of activity is typically shorter." This correction has been made to the online version as of March 10, 2017.
